Our products are verified by independent third party laboratories to meet quality standards
BPC-157 TB500 KPV GHK-Cu KLOW Blend (BPC-157 | TB500 | GHK-Cu | KPV) CERTIFICATES OF ANALYSIS 2 COAs BN-26KL80-002 Current Variant: Size: klow-80 BPC-157 12.21 mg / 11.79 mg TB-500 11.34 mg / 10.98 mg KPV 11.54 mg / 11.17 mg GHK-Cu 61.33 mg / 59.29 mg BN-26KL80-001 Previous Variant: Size: klow-80 Formulation KLOW is a multi-peptide research formulation combining BPC-157, TB-500 (Thymosin Beta-4 fragment), GHK-Cu, and KPV, supplied for use in controlled laboratory and analytical environments
The standard dose mirrors asthma treatment at 0.63 to 1.25 mg via nebulizer
It upregulates genes involved in collagen synthesis (COL1A1, COL3A1, COL5A1), extracellular matrix remodeling (decorin, fibromodulin), and antioxidant defense (superoxide dismutase, glutathione peroxidase) while simultaneously suppressing genes associated with inflammation (IL-6, TNF-alpha), fibrinogen production, and tissue destruction (several MMPs)
The researchers reported higher VEGFR2 mRNA and protein expression after BPC-157 exposure
